Association Between Homocysteinemia and Renal Function in Patients with Type 2 Diabetes Mellitus
|
|
- Oswin Cole
- 5 years ago
- Views:
Transcription
1 Annals of Clinical & Laboratory Science, vol. 32, no. 3, Association Between Homocysteinemia and Renal Function in Patients with Type 2 Diabetes Mellitus Bilgin Ozmen, 1 Dilek Ozmen, 2 Nevbahar Turgan, 2 Sara Habif, 2 Isil Mutaf, 2, and Oya Bayindir 2 1 Department of Endocrinology, Celal Bayar University School of Medicine, Manisa, Turkey, and 2 Department of Clinical Biochemistry, Ege University School of Medicine, Izmir, Turkey Abstract. Homocysteinemia is an independent risk factor for cardiovascular disease, but information on its association with type 2 diabetes and mild renal dysfunction is limited. Plasma total homocysteine (thcy) concentration is partly determined by renal plasma clearance. Serum cystatin C (Cys C) concentration has been introduced as a marker of renal function, specifically as an indicator of glomerular filtration rate (GFR). The aim of this study was to explore the relationships among thcy, creatinine clearance (Ccr), serum Cys C, and microalbuminuria in a population with type 2 diabetes. Fasting plasma thcy, serum homocysteine-related vitamins (folate and vitamin B 12 ), serum Cys C, serum creatinine, urine microalbumin, and creatinine clearance were determined in 75 type 2 diabetic patients and 40 healthy control subjects. The patients were assigned to two groups based on urinary albumin excretion (UAE): normoalbuminuric (NAU, UAE <30 mg/24 hr, n = 35) and microalbuminuric (MAU, UAE mg/24 hr, n = 40). Ccr was calculated using the Cockroft-Gault formula. Plasma Hcy levels were determined by HPLC with fluorescence detection and serum Cys C by automated particle enhanced immunoturbidimetry. Plasma thcy levels were significantly higher in normoalbuminuric and microalbuminuric patients than in controls (10.64 ± 0.53, ± 0.78, 6.91 ± 0.37 mmol/l, respectively). Serum Cys C levels in microalbuminuric diabetics were higher than in normoalbuminurics and controls (1.36 ± 0.06, 1.12 ± 0.04, 1.10 ± 0.06 mg/ L, respectively). Positive correlations were noted between thcy and Cys C levels in normoalbuminuric and microalbuminuric diabetics (r = 0.72, r = 0.64, respectively ). Homocysteine and creatinine concentrations were correlated in both diabetic groups (r = 0.89, r = 0.93, NAU and MAU, respectively ). Elevated plasma total homocysteine concentrations in type 2 diabetics suggest an association between homocysteinemia and deterioration of renal function, evidenced by increased serum creatinine and Cys C, Ccr, and microalbuminuria. These findings implicate homocysteinemia in the relationship between diabetic nephropathy and cardiovascular complications of diabetes. (received 8 February 2002, accepted 25 March 2002) Keywords: diabetes mellitus type 2, homocysteine, cystatin C, microalbuminuria, renal function Introduction Homocysteine (Hcy) is the transmethylation product of the essential sulphur-containing amino acid methionine [1,2]. Experiments have shown that high concentrations of homocysteine may cause vascular damage [3]. Epidemiological research Address correspondence to Dilek Ozmen, M.D., Department of Clinical Biochemistry, Ege University School of Medicine, 35100, Bornova, Izmir, Turkey; tel and fax ; dozmen@med.ege.edu.tr. suggests an association between elevated total homocysteine (thcy) levels and cardiovascular disease (CVD), which is the most common cause of mortality in patients with type 2 diabetes mellitus [2]. The association between homocysteinemia and atherosclerotic vascular disease is especially strong in patients with type 2 diabetes, compared to nondiabetic subjects. Increased plasma thcy levels are reported to be associated with hypertension, hyperlipidemia, smoking, hyperuricemia, and impaired adrenal function [4-8]. Plasma thcy /02/0300/0279, $ by the Association of Clinical Scientists, Inc.
2 280 Annals of Clinical & Laboratory Science concentration is strongly related to renal function [9]. A study in rats identified the kidney as a major site for removal and metabolism of Hcy [10]. Two mechanisms appear to be involved. The main source of Hcy is adenosylmethionine-dependent methylation of guanidoacetate to form creatine and its anhydride creatinine [11]. Second, renal function plays a central role for clearance of both creatinine and Hcy [12,13]. Plasma thcy concentrations in diabetic patients can be affected by both glomerular hyper- and hypofiltration, which can respectively decrease and increase the thcy concentrations [14,15]. However, reduced glomerular filtration rate (GFR) accompanies microalbuminuria (MAU) in the late phase of diabetic nephropathy, and reduction of GFR causes elevation of plasma Hcy levels [16,17]. These data provide a potential link between microalbuminuria, diabetic nephropathy and cardiovascular disease [18-20]. Despite some disadvantages, in clinical practice serum creatinine and creatinine clearance determinations are routinely used for the estimation of GFR in diabetic patients. Recently, serum cystatin C (Cys C) concentration has been introduced as a new marker of renal function, specifically as an indicator of the GFR. Cys C comprises one non-glycosylated polypeptide chain with 120 amino acid residues (mol wt 13 kda) [21]. Investigations have indicated that serum Cys C is superior to serum creatinine for the detection of early decreases of GFR [21-24]. In contrast to serum creatinine, Cys C is not related to muscle mass or the formation of creatinine; it only reflects the GFR [22,25]. GFR is proposed as an independent determinant of plasma thcy and a rate limiting parameter for renal clearance of homocysteine and cysteine in diabetic patients without overt nephropathy [13,14]. Based on these considerations, this study was designed to assess the association between plasma thcy and serum Cys C for the evaluation of renal function in type 2 diabetic patients. Materials and Methods This study included 75 patients (30 men, 45 women, age yr) with type 2 diabetes mellitus, with or without microalbuminuria, who received care at the Department of Endocrinology of Celal Bayar University Hospital. Their diagnosis of diabetes mellitus was based on a previous history of diabetes or the American Diabetes Association (ADA) criteria [26] questionnaire, which includes age, duration of diabetes, use of medication for diabetes, vitamin supplementation, smoking habits, and ethanol intake. The control group consisted of 40 healthy subjects (18 men, 22 women, age yr) who were screened by a physician for signs of diabetes mellitus and who did not show any clinical evidence of the disease. The subjects were all informed about the protocol and their written consent was obtained. The diabetic patients were divided into two groups based on their urinary albumin excretion (UAE). Group 1 included 35 patients with normoalbuminuria (NAU), (UAE <30 mg/24 hr); Group 2 included 40 patients with microalbuminuria (MAU), (UAE mg/24 hr). HbA ıc, creatinine, homocysteine, folate, vitamin B 12 and cystatin C concentrations were determined in blood or serum samples after an overnight fast. Urine albumin excretion was measured in 24 hr urine specimens. Among the diabetic patients, 42 were treated with sulphonylurea drugs, 10 with combinations of sulphonylurea and alpha-glucosidase inhibitors, and 23 with insulin. Serum creatinine concentrations were analyzed by standard laboratory methods with an automatic analyzer (Technicon Dax-48, Bayer Diagnostics, Toshiba, Japan). HbA ıc and urine albumin excretion were measured by immunoturbidimetric assay kits (Roche Diagnostic GMBH, Germany) with a Hitachi 704 analyzer (Tokyo, Japan). Creatinine clearance in males was calculated by the Cockroft-Gault formula [27]: (140-age) x weight kg / 72 x serum creatinine mg/100ml. For females, the value obtained by this equation was multiplied by 0.85.
3 Plasma homocysteine and renal function in diabetics 281 Serum cystatin C levels were determined by a latex particle enhanced immunoturbidimetric assay (DAKO, Glostrop, Denmark). Folate and vitamin B 12 in serum were measured by a chemiluminescent immunoassay (Access, Sanofi Diagnostics Pasteur, Marnes La Coquette, France); the reference intervals were >6.8 nmol/l for folate and 133 to 675 pmol/ L for vitamin B 12. For homocysteine analyses, blood was collected in EDTA-containing tubes; the plasma was separated within min and stored at -20 C. Total homocysteine (thcy) in plasma was measured by HPLC and fluorescence detection [28]. A Shimadzu LC 10A HPLC system (Shimadzu Corp., Kyoto, Japan) was used, consisting of a Shimadzu LC-10AD pump, a Shimadzu SIL-10AXL autoinjector with a 20 µl loop, and a Shimadzu RF-10AXL fluorescence detector. The system was controlled through a Shimadzu CBM-10A communication module and a personal computer. The column was EC 150/4.6 Nucleosil C18 5 mm (Macherey-Nagel, Duren, Germany). Tri-n-butyl-phosphine (TBP) in dimethly formamide (DMF) was applied for reduction of disulfide-bound homocysteine and ammonium 7-fluorobenzo-2-oxa-1,3-diazide-4- sulphonate (SBDF) served as a derivatization agent. Cysteamine hydrochloride was added as an internal standard. Results are reported as mean ± SE. Differences in mean values of the three groups were evaluated by the t-test (p <0.05 was considered significant). Correlations were tested by the Pearson rank correlation test. The Statistical Package for Social Sciences (SPSS Version 7.5, SPSS Inc., Chicago, IL, USA) was used. Results Laboratory findings of patients and control subjects are listed in Table 1. There were no significant differences in age or sex between the two diabetic groups and the controls. Plasma homocysteine, serum cystatin C, and serum creatinine concentrations showed significant differences between the two diabetic groups. Creatinine clearance values were lower in both diabetic groups (p < 0.01 for both values), compared to controls. Serum folate and vitamin B 12 concentrations are not included in Table 1, since these parameters were used only to exclude deficiencies of these vitamins that could affect thcy levels. All subjects had folate concentrations >6.8 nmol/l and vitamin B 12 concentrations between 133 and 675 pmol/l. Mean plasma homocysteine concentrations were significantly higher in normo- and microalbuminuric diabetic patients than in the controls (10.64 ± 0.53 and ± 0.78 vs 6.91 ± 0.37 µmol/l, respectively, p < 0.01) The mean serum cystatin C concentration in microalbuminuric patients was higher than in normoalbuminuric patients and controls (1.36 ± 0.06, 1.12 ± 0.04, and 1.10 ± 0.06 mg/l, respectively, p <0.01) The difference between normoalbuminuric diabetics and controls was insignificant. Serum creatinine levels in microalbuminuric patients were higher than in normoalbuminuric patients and controls ( ± 4.42, ± 3.54, and ± 2.86 µmol/l, respectively, p <0,01) There were no significant differences in serum creatinine levels between normoalbuminuric diabetics and control subjects. Mean creatinine clearance values in normo- and microalbuminuric groups were higher than in controls (60.50 ± 5.19 and ± 3.49, versus ± 0.06 ml/min, respectively, p < 0,01). In normoalbuminuric diabetics, positive correlations were observed between plasma homocysteine and serum cystatin C concentrations (r = 0.72, p <0.01, Fig. 1a), between plasma homocysteine and serum creatinine levels (r = 0.89, p <0.01) (Fig. 1b), and between plasma homocysteine and age (r = 0.48, p <0.01) (Table 2). In microalbuminuric diabetic patients, there were positive correlations between plasma homocysteine and serum cystatin C levels (r = 0.64, p <0.01) (Fig. 2a), homocysteine and serum creatinine levels (r = 0.93, p <0.01) (Fig. 2b), and homocysteine and age (r = 0.58, p <0.01) (Table 2).
4 282 Annals of Clinical & Laboratory Science Table 1. Summary of the data (mean ± SE) for diabetic patients and healthy controls Parameter Control Normoalbuminuric Microalbuminuric p subjects diabetic patients diabetic patients (n = 40) (NAU) (n = 35) (MAU) (n = 40) Plasma homocysteine (µmol/l) 6.91 ± ± ± 0.78 a,b,c Serum cystatin C (mg/l) 1.10 ± ± ± 0.06 b,c Serum creatinine (µmol/l) 82.21± ± ± 5.65 b,c Creatinine clearance (ml/min) ± ± ± 3.49 a,b Blood HbA ıc (%) 5.54 ± ± ± 0.45 ns Urine microalbumin (mg/24 hr) 13.25± ± ± b,c Age (yr) ± ± ± 1.96 ns Duration of diabetes (yr) 9.7 ± ± 1.2 ns a p <0.01; NAU versus controls b p <0.01; MAU versus controls c p <0.01; MAU versus NAU ns = not significant Table 2. Pearson s correlation coefficient (r) and p values for determinants of plasma homocysteine concentrations in diabetic patients Parameter Plasma homocysteine concentration (µmol/l) Normoalbuminuric Microalbuminuric diabetic patients diabetic patients (n = 35) (n = 40) r p r p Serum cystatin C (mg/l) 0.72 < <0.01 Serum creatinine (µmol/l) 0.89 < <0.01 Age (yr) 0.48 < <0.01
5 Plasma homocysteine and renal function in diabetics 283 Fig. 1a (left panel) and Fig. 1b (right panel) show the graphs and regression equations for comparisons between plasma homocysteine and serum cystatin C (1a) and plasma homocysteine and serum creatinine (1b) concentrations in normoalbuminuric diabetic patients. Fig. 2a (left panel) and Fig. 2b (right panel show the graphs and regression equations for the comparisons between plasma homocysteine and serum cystatin C (2a) and plasma homocysteine and serum creatinine (2b) concentrations in microalbuminuric diabetic patients
6 284 Annals of Clinical & Laboratory Science No significant correlations were observed between any of the parameters in healthy controls. Discussion Growing interest is being focused on the association of homocysteinemia with diabetes mellitus. However, consensus on how type 2 diabetes affects plasma homocysteine concentrations has not been achieved [2]. Homocysteinemia has been established as a risk factor for cardiovascular disease and occurs with high prevalence in patients with type 2 diabetes: 31% of type 2 diabetic patients have homocysteine concentrations above >15 mmol/l [29]. Only a few studies found no significant differences in fasting plasma thcy levels between type 2 diabetic patients without microalbuminuria and healthy control subjects [30]. A large amount of evidence supports increased plasma thcy levels in type 2 diabetes [2,4, 15,18,20,29,31,32]. Buysschaert et al [29] reported increased plasma thcy levels in type 2 diabetics with advanced nephropathy, compared to control subjects and diabetics without nephropathy. The relationship between homocysteinemia and microalbuminuria is more problematic. Some authors found an association between plasma thcy and microalbuminuria in diabetes [2,18,30,33,34], while others did not [32,35]. In our study, plasma homocysteine concentrations were significantly higher in microalbuminuric patients than in normoalbuminuric patients or controls. Chico et al [18], Emoto et al [2], and Lanfredini et al [30] found strong association between homocysteinemia and deteriorated renal function. According to previous reports, homocysteine is ultrafiltrated through the glomeruli, almost completely reabsorbed in the tubuli, and degraded in kidney tissue by transmethylation and transsulfuration [36]. Decreased renal clearance of homocysteine results in homocysteinemia [10-12], but the exact mechanism is unknown [37]. Recently, serum cystatin C has been introduced as a more sensitive marker for mildly impaired GFR, compared to creatinine and GFR, and also as an independent determinant of plasma thcy concentrations [21,22]. Norlund et al [17] suggested that the increase of plasma homocysteine concentrations with advancing age may be due to age-related decline in renal function. It has also been shown that cystatin C shows a higher predictive value for thcy concentrations than age or serum creatinine [17]. Our data indicate that serum cystatin C levels in patients with microalbuminuria were significantly higher than in patients with normoalbuminuria or control subjects. Additionally, we found that plasma homocysteine concentrations correlated better with serum creatinine than with serum cystatin C. Our data are in agreement with the study of Abdella et al [31], who also showed that plasma homocysteine concentrations correlated better with serum creatinine than with cystatin C, presumably because of the relationship between creatine-creatinine synthesis and homocysteine production. Contradicting these data, Bostom et al [38] and Aras et al [39] reported that serum cystatin C was a much better predictor of fasting total homocysteine concentrations in renal transplant recipients with normal renal function. In patients with coronary artery disease and normal renal function (serum creatinine concentrations < µmol/l), serum cystatin C was reported to be an independent predictor of fasting thcy concentrations [40]. Although kidney function plays an important role in the metabolism of homocysteine, it is not clear whether homocysteinemia is associated with or can precede microalbuminuria [5,41]. Homocysteinemia is believed to increase the risk of atherothrombic disease directly by impairing endothelial function, stimulating vascular smooth muscle cell proliferation, and altering extracellular matrix properties [42]. High plasma homocysteine levels may also exert an atherothrombic effect by inducing oxidative stress, which may impair endothelial function. Oxidative stress is thought to be increased in type 2 diabetes [43]. Thus, homocysteinemia may contribute to the development of renal impairment and subsequent microalbuminuria in diabetic patients through increased oxidative stress [5]. In summary, the present study shows that plasma homocysteine concentrations are elevated in type 2 diabetic patients with and without microalbuminuria. Microalbuminuric type 2 diabetic patients have higher plasma homocysteine levels than normoalbuminuric patients and controls.
7 Plasma homocysteine and renal function in diabetics 285 Elevated plasma homocysteine concentrations in type 2 diabetic patients suggest an association between homocysteinemia and impaired renal function, as evidenced by increased serum creatinine and cystatin C levels. These findings suggest that homocysteinemia may partly explain the link between diabetic nephropathy and cardiovascular complications of diabetes. References 1. Medina MA, Amores-Sanchez MI. Homocysteine : an emergent cardiovascular risk factor? Eur J Clin Invest 2000;30: Emoto M, Kanda H, Shoji T, Kawagishi T, Komatsu M, Mori K, Tahara H, Ishimura E, Inaba M, Okuno Y, Nishizawa Y. Impact of ınsulin resistance and nephropathy on homocysteine in type 2 diabetes. Diabetes Care 2001;24: Stamler JS, Osborne JA, Jaraki O, Rabbanı LE, Mullins M, Sıngel D, Loscalzo J. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing oxides of nitrogen. J Clin Invest 1993;91: Fiorina P, Lanfredini M, Montanari A, Peca MG, Verpnelli A, Mello A, Astorri E, Craveri A. Plasma homocysteine and folate are related to arterial blood pressure in type 2 diabetes mellitus. Am J Hypertens 1998;11: Hoogeveen EK, Kostense PJ, Jager A, Heine RJ, Jakobs C, Bouter LM, Donker AJ, Stehouwer CD. Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study. Kidney Int 1998;54: Munshi MN, Stone A, Fink L, Fonseca V. Homocysteinemia following a methionine load in patients with noninsulın dependent diabetes mellitus and macrovascular disease. Metabolism 1996;45: Okada E, Oida K, Tada H, Asazuma K, Eguchi K, Tohda G, Kosaka S, Takahashi S, Miyamori I. Homocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes. Diabetes Care 1999;22: Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerned Action Project. JAMA 1997;277: Bostom AG, Lathrop L. Homocysteinemia in end stage renal disease : prevalence, etiology and potential relationship to arteriosclerotic outcomes. Kidney Int 1997;52: House JD, Brosnan ME, Brosnan JT. Characterization of homocysteine metabolism in the rat kidney. Biochem J 1997;328: Brattström L, Lindgren A, Israelsson B, Andersson A, Hultberg B. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 1994;236: Bostom A, Brosnan JT, Hall B, Nadeau MR, Selhub J. Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclerosis 1995;116: Arnadottir M, Hultberg B, Nilsson-Ehle P, Thysell H. The effect of reduced glomerular filtration rate on plasma total homocysteine concentration. Scand J Clin Lab Invest 1996;56: Wollesen F, Brattström L, Refsum H, Ueland PM, Berglund L Berne C. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int 1999;55: Hultberg B, Agardh E, Andersson A, Brattström L, Isaksson A, Israelsson B, Agardh CD. Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type 1 diabetes mellitus. Scand J Clin Lab Invest 1991;51: Hultberg B, Andersson A, Sterner G. Plasma homocysteine in renal failure. Clin Nephrol 1993; 40: Norlund L, Grubb A, Fex G, Lksell H, Nilsson JE, Schenck H, Hultberg B. The increase of plasma homocysteine with age is partly due to the deterioration of renal function as determined by plasma cystatin C. Clin Chem Lab Med 1998;36: Chico A, Perez A, Cordoba A, Arcelus R, Carreras G, de Leiva A, Gonzales-Sastre F, Blanco-Vaca F. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia 1998;41: Hoogeveen EK, Kostense PJ, Beks PJ, Mackay AJ, Jakobs C, Bouter LM, Heine RJ, Stehouwer CD. Homocysteinemia is associated with an increased risk of cardivascular disease, especially in non-insulin dependent diabetes mellitus. a population-based study. Arterioscler Thromb Vasc Biol 1998;18: Stabler SP,. Estacio R,.Jeffers B W,. Cohen JA, Allen R H,.Schrier RW, Total homocysteine is associated with nephropathy in non-insulin-dependent diabetes mellitus. Metabolism 1999;48: Randers E, Erlandsen EJ, Serum cystatin C as an endogenous marker of the renal function: a review. Clin Chem Lab Med 1999; 7:
8 286 Annals of Clinical & Laboratory Science 22. Newman DJ, Thakkar H, Edwards RG,. Wilkie M, White T, Grubb AO. Price Serum cystatin C measured by automated immunassay: a more sensitive marker of changes in GFR than serum creatinine, Kidney Int. 1995;47: Filler G, Witt I, Priem F, Ehrich JH, Jung K, Are cystatin C and beta 2 -microglobulin better markers than serum creatinine for prediction of a normal GFR in pediatric subjects? Clin Chem 1997; 43: Mojiminiyi OA, Shayji IA, George S. Serum cystatin could replace serum creatinine as an indicator of GFR in routine practice. Eur J Lab Med 1998;6: Kyhse-Andersson J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindström V, et al. Serum cystatin C, determined by a rapid automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for GFR. Clin Chem 1994;40: Expert Committee on Diabetes Mellitus. The Expert Committee s report on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20: Cockroft DW, Gault DA. Prediction of creatinine clearance from creatinine. Nephron 1976;16: Turgan N, Boydak B, Habif S, Apakkan S, Özmen D, Mutaf I, Bayındır O. Plasma homocysteine levels in acute coronary syndromes. Jpn Heart J 1999;40: Buysschaert M, Dramaıs AS, Wallemaco PE, Hermansa MP. Homocysteinemia in type 2 diabetes. Diabetes Care 2000;23: Lanfredini M, Fiorina P, Peca MG, Veronelli A, Mello A, Astorri E, Dall Aglio P, Craveri A. Fasting and post-methionine load homocyst(e)ine values are correlated with microalbuminuria and could contribute to worsening vascular damage in noninsulin-dependent diabetes mellitus. Metabolism 1998;47: Abdella N, Mojiminiyi OA, Akanji AO., Homocysteine and endogenous markers of renal function in type 2 diabetic patients without coronary heart disease. Diabetes Res Clin Pr 2000;50: Smulders YM, Rakie M, Slaats EH, Treskes M, Sijbrands EJ, Oderkerken DA, Stehouwer CD, Silberbusch J. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria and cardiovascular disease. Diabetes Care 1999;22: Hofmann MA, Kohl B, Zumbach MS,Borcea V, Bierhaus A, Henkels M, Amiral J,Schmidt AM, Fiehn W, Ziegler R, Nawroth PP. Homocyst(e)ine and endothelial dysfunction in IDDM. Diabetes Care 1998;21: Agardh CD, Agardh E, Andersson A, Hultberg B. Lack of association between plasma homocysteine levels and microangiopathy in type I diabetes mellitus. Scand J Clin Lab Invest 1994;54: Baliga BS, Reynolds T, Fink LM, Fonseca VA. Homocysteinemia in type 2 diabetes mellitus: cardiovascular risk factors and effect of treatment with folic acid and pyridoxine. Endocr Pract 2000; 6: Dudman NP, Guo XV, Gordon RB, Dawson PA, Wılcken DE. Human homocysteine catabolism: Three major pathways and their relevance to develoment of arterial occlusive disease. J Nutr 1996;126 : 1295S-3000S. 37. Guttormsen AB, Ueland PM, Svarstad E, Refsum H. Kinetic basis of homocysteinemia in patients with chronic renal failure. Kidney Int 1997;52: Bostom AG, Gohh RY, Bausserman L, Hakas D, Jacques PF, Selhub J, Dworkin L, Rosenberg IH. Serum cystatin C as a determinant of fasting total homocysteine levels in renal recipients with a normal serum creatinine. J Am Soc Neph 1999;10: Aras Ö, Tsai MY, Hanson NQ, Bailey R, Rao G, Hunnınghake DB. Cystatin C is an independent predictor of fasting and post-methionine load total homocysteine concentrations among stable transplant recipients.clin Chem 2001;47: Bostom AG, Bausserman L, Jacques PF, Liaugaudas G, Selhub J, Rosenberg IH. Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine. Arterioscler Thromb Vasc Biol 1999; 19: Jager A, Kostense PJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Donker AJ, Stehouwer CD. Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn Study. Arterioscler Thromb Vasc Biol 2001;21: Stehouwer CDA, Gall MA, Hougaard P, Jakobs C, Parving HH. Plasma homocysteine concentration predicts mortality in non-insulin dependent diabetic patients with and without microalbuminuria. Kidney Int 1999;55: Hoogeveen EK, Kontense PJ, Jakobs C, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CDA. Homocysteinemia increases risk of death, especially in type 2 diabetes. Circulation 2000;101:
Relationship to macroangiopathy, nephropathy, and insulin resistance. Diabetes Care 23: , 2000
Pathophysiology/Complications O R I G I N A L A R T I C L E Hyperhomocysteinemia in Type 2 Diabetes Relationship to macroangiopathy, nephropathy, and insulin resistance MARTIN BUYSSCHAERT, MD ANNE-SOPHIE
More informationInternational Journal of Pharma and Bio Sciences IS CYSTATIN C ESTIMATION A BETTER MARKER IN CHRONIC KIDNEY DISEASE PATIENTS?
International Journal of Pharma and Bio Sciences RESEARCH ARTICLE BIO CHEMISTRY IS CYSTATIN C ESTIMATION A BETTER MARKER IN CHRONIC KIDNEY DISEASE PATIENTS? Corresponding Author R.KUMARESAN Department
More informationCorrelation of plasma concentrations of cystatin C and creatinine to inulin clearance in a pediatric population
Clinical Chemistry 44:6 1334 1338 (1998) General Clinical Chemistry Correlation of plasma concentrations of cystatin C and creatinine to inulin clearance in a pediatric population Douglas Stickle, 1 Barbara
More informationTo study the association between plasma homocysteine and microvascular and macrovascular complications in type 1 Diabetes Mellitus.
ORIGINAL RESEARCH PAPER INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH To study the association between plasma homocysteine and microvascular and macrovascular complications in type 1 Diabetes Mellitus.
More informationPlasma total homocysteine and macrovascular complications are associated with food and nutrient intake in patients with Type II diabetes mellitus
Nutrition Research and Practice (2007), 2, 79-83 c2007 The Korean Nutrition Society and the Korean Society of Community Nutrition Plasma total homocysteine and macrovascular complications are associated
More informationTotal plasma homocysteine is associated with hypertension in Type I diabetic patients
Diabetologia (2002) 45:1315 1324 DOI 10.1007/s00125-002-0908-4 Total plasma homocysteine is associated with hypertension in Type I diabetic patients S. Neugebauer 1, L. Tarnow 2, C. Stehouwer 3, T. Teerlink
More informationComparison of Serum Cystatin C and Creatinine Levels to Evaluate Early Renal Function after Kidney Transplantation
IJMS Vol 34, No 2, June 2009 Original Article Comparison of Serum Cystatin C and Creatinine Levels to Evaluate Early Renal Function after Kidney Transplantation Reza Hekmat, Hamid Eshraghi Abstract Background:
More informationScreening for chronic kidney disease racial implications. Not everybody that pees has healthy kidneys!
Screening for chronic kidney disease racial implications Not everybody that pees has healthy kidneys! Screening for chronic kidney disease racial implications 1) Definition of CKD 2) Why should we screen
More informationSerum homocysteine level and protein intake are related to risk of microalbuminuria: The Hoorn Study 1
Kidney International, Vol. 54 (1998), pp. 203 209 Serum homocysteine level and protein intake are related to risk of microalbuminuria: The Hoorn Study 1 ELLEN K. HOOGEVEEN, PIETER J. KOSTENSE, AGNES JAGER,
More informationSerum total homocysteine concentration before and after renal transplantation
Kidney International, Vol. 54 (1998), pp. 1380 1384 Serum total homocysteine concentration before and after renal transplantation MARGRET ARNADOTTIR, BJÖRN HULTBERG, JAN WAHLBERG, BENGT FELLSTRÖM, and
More informationInsulin Resistance Is Not Related to Plasma Homocysteine Concentration in Healthy Premenopausal Women
Physiol. Res. 55: 285-29, 26 Insulin Resistance Is Not Related to Plasma Homocysteine Concentration in Healthy Premenopausal Women F. TANRIKULU-KILIÇ, S. BEKPINAR, Y. ÜNLÜÇERÇI, Y. ORHAN 1 Department of
More informationAssessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation
Nephrol Dial Transplant (2002) 17: 1909 1913 Original Article Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new () prediction equation
More informationRecently, carotid B-mode ultrasound imaging has been
Plasma Homocysteine Levels and Atherosclerosis in Japan Epidemiological Study by Use of Carotid Ultrasonography Hisashi Adachi, MD, PhD; Yuji Hirai, MD; Yoshihisa Fujiura, MD; Hidehiro Matsuoka, MD, PhD;
More informationSerum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy. Christensson, Anders; Grubb, Anders; Nilsson, J-A; Norrgren, Kristina; Sterner,
More informationORIGINAL ARTICLE Urinary type IV collagen levels in diabetes mellitus
Malaysian J Pathol 21; 32(1) : 43 47 ORIGINAL ARTICLE Urinary type IV collagen levels in diabetes mellitus Pavai STHANESHWAR MBBS, MD and *Siew-Pheng CHAN MBBS, FRCP Departments of Pathology and *Medicine,
More informationEvaluation of the Cockroft Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients
Original article Annals of Oncology 15: 291 295, 2004 DOI: 10.1093/annonc/mdh079 Evaluation of the Cockroft Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients G.
More informationCauses of Hyperhomocysteinemia in Patients With Chronic Kidney Diseases
Causes of Hyperhomocysteinemia in Patients With Chronic Kidney Diseases Giacomo Garibotto, Antonella Sofia, Alessandro Valli, Alice Tarroni, Massimiliano Di Martino, Valeria Cappelli, Francesca Aloisi,
More informationPrevention And Treatment of Diabetic Nephropathy. MOH Clinical Practice Guidelines 3/2006 Dr Stephen Chew Tec Huan
Prevention And Treatment of Diabetic Nephropathy MOH Clinical Practice Guidelines 3/2006 Dr Stephen Chew Tec Huan Prevention Tight glucose control reduces the development of diabetic nephropathy Progression
More informationHypertension and diabetic nephropathy
Hypertension and diabetic nephropathy Elisabeth R. Mathiesen Professor, Chief Physician, Dr sci Dep. Of Endocrinology Rigshospitalet, University of Copenhagen Denmark Hypertension Brain Eye Heart Kidney
More informationOutline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD?
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationOutline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationE.Ritz Heidelberg (Germany)
Predictive capacity of renal function in cardiovascular disease E.Ritz Heidelberg (Germany) If a cure is not achieved, the kidneys will pass on the disease to the heart Huang Ti Nei Ching Su Wen The Yellow
More informationand Folic Acid in Type II Diabetes Mellitus Patients.
Research Article ISSN: 974-6943 M. Prabhuet al. / Journal of Pharmacy Research 214,8(1),1398-145 Available online through http://jprsolutions.info Investigation of the Effect of on the Level of Plasma
More informationPredictors of Change in Plasma Total Cysteine: Longitudinal Findings from the Hordaland Homocysteine Study
Clinical Chemistry 49:1 113 120 (2003) Lipids, Lipoproteins, and Cardiovascular Risk Factors Predictors of Change in Plasma Total Cysteine: Longitudinal Findings from the Hordaland Homocysteine Study Lina
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Control of Hypercholesterolaemia and Progression of Diabetic Nephropathy
Control of Hypercholesterolaemia and Progression of Diabetic Nephropathy Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES a. All hypercholesterolaemic diabetics
More informationSerum cystatin C is not a better marker of creatinine or digoxin clearance than serum creatinine
Serum cystatin C is not a better marker of creatinine or digoxin clearance than serum creatinine S. O Riordan, E. Ouldred, S. Brice, S. H. D. Jackson & C. G. Swift Clinical Age Research Unit, Department
More informationJMSCR Vol 05 Issue 07 Page July 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i7.36 Evaluation of C-Reactive Protein Levels
More informationISSN: Asian Journal of Medical and Pharmaceutical Researches Asian J. Med. Pharm. Res. 4(2): , 2014
\\\\ Received 12 Apri. 2014 Accepted 25 May. 2014 ORIGINAL ARTICLE 2014 Scienceline Publication www.science-line.com ISSN: 2322-4789 Asian Journal of Medical and Pharmaceutical Researches Asian J. Med.
More informationClinical Study Factors Associated with the Decline of Kidney Function Differ among egfr Strata in Subjects with Type 2 Diabetes Mellitus
International Endocrinology Volume 2012, Article ID 687867, 6 pages doi:10.1155/2012/687867 Clinical Study Factors Associated with the Decline of Kidney Function Differ among egfr Strata in Subjects with
More informationOutline. Outline 10/14/2014 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationA Comparison Of Diagnostic Accuracy Of Cystatin C With Creatinine In The Sample Of Patient Of T2 DM With Diabetic Nephropathy
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 7 Ver. V (July. 2017), PP 53-57 www.iosrjournals.org A Comparison Of Diagnostic Accuracy Of
More informationΕκηίμηζη ηης μεθρικής λειηοσργίας Ε. Μωραλίδης
Εκηίμηζη ηης μεθρικής λειηοσργίας Ε. Μωραλίδης Ιατρική Σχολή ΑΠΘ Νοσοκομείο ΑΧΕΠA Θεσσαλομίκη Kidney in body homeostasis Excretory function Uremic toxins removal Vascular volume maintainance Fluid-electrolyte
More informationCystatin C (serum, plasma, urine)
Cystatin C (serum, plasma, urine) 1 Name and description of analyte 1.1 Name of analyte Cystatin C (serum, plasma and urine) 1.2 Alternative names Cystatin 3, post-gamma-globulin, neuroendocrine basic
More information* id of the corresponding author- Received: 23/07/2017 Revised:25/11/2017 Accepted:09/12/2017 ABSTRACT
International Journal of Medical Science and Education An official Publication of Association for Scientific and Medical Education (ASME) Original Research Article THE ASSOCIATION OF PLASMA HOMOCYSTEINE
More informationA New Approach for Evaluating Renal Function and Its Practical Application
J Pharmacol Sci 105, 1 5 (2007) Journal of Pharmacological Sciences 2007 The Japanese Pharmacological Society Current Perspective A New Approach for Evaluating Renal Function and Its Practical Application
More information5/10/2014. Observation, control of blood pressure. Observation, control of blood pressure and risk factors.
Overview The Kidneys Nicola Barlow Clinical Biochemistry Department City Hospital Renal physiology Renal pathophysiology Acute kidney injury Chronic kidney disease Assessing renal function GFR Proteinuria
More informationORIGINAL INVESTIGATION. Hyperhomocysteinemia Is Associated With the Presence of Retinopathy in Type 2 Diabetes Mellitus
Hyperhomocysteinemia Is Associated With the Presence of Retinopathy in Type 2 Diabetes Mellitus The Hoorn Study ORIGINAL INVESTIGATION Ellen K. Hoogeveen, MD; Pieter J. Kostense, PhD; Petra E. D. Eysink,
More informationCystatin C and renal function in pediatric renal transplant recipients
ISSN 0100-879X Volume 42 (12) 1119-1247 December 2009 BIOMEDICAL SCIENCES AND CLINICAL INVESTIGATION Braz J Med Biol Res, December 2009, Volume 42(12) 1225-1229 Cystatin C and renal function in pediatric
More informationDIABETIC NEPHROPATHY AND ITS RELATION TO INFLAMMATION
Page117 Research Article Biological Sciences DIABETIC NEPHROPATHY AND ITS RELATION TO INFLAMMATION Vivek Manik Patil 1,Chaitanyakumar S 2, Venaktesh Patil 3, Rajeshawri R Surpur 4, Vijayanath.V 5 1 Associate
More informationGlomerular Filtration Rate. Hui Li, PhD, FCACB, DABCC
Glomerular Filtration Rate Hui Li, PhD, FCACB, DABCC Glomerular Filtration Rate (GFR): Amount of blood that is filtered per unit time through glomeruli. It is a measure of the function of kidneys. The
More informationHigher levels of Urinary Albumin Excretion within the Normal Range Predict Faster Decline in Glomerular Filtration Rate in Diabetic Patients
Diabetes Care Publish Ahead of Print, published online May 12, 2009 Albuminuria and GFR Decline in Diabetes Higher levels of Urinary Albumin Excretion within the Normal Range Predict Faster Decline in
More informationSummary of Recommendation Statements Kidney International Supplements (2013) 3, 5 14; doi: /kisup
http://www.kidney-international.org & 2013 DIGO Summary of Recommendation Statements idney International Supplements (2013) 3, 5 14; doi:10.1038/kisup.2012.77 Chapter 1: Definition and classification of
More informationKidney and heart: dangerous liaisons. Luis M. RUILOPE (Madrid, Spain)
Kidney and heart: dangerous liaisons Luis M. RUILOPE (Madrid, Spain) Type 2 diabetes and renal disease: impact on cardiovascular outcomes The "heavyweights" of modifiable CVD risk factors Hypertension
More informationScope of the talk. Riboflavin, other dairy B vitamins and cardiovascular health. Epidemiology of milk consumption and CVD
Riboflavin, other dairy B vitamins and cardiovascular health Professor Hilary J Powers University of Sheffield United Kingdom Scope of the talk Importance of dairy products to B vitamin intakes Epidemiological
More informationNature and Science 2018;16(9)
Serum Cystatin C and Beta-2-microglobulin as Early Biomarkers of Diabetic Nephropathy in Patients with Type II Diabetes Mellitus Sherief El-Ghannam 1, Mahmoud Bastawy 2, Mekky Abdel-Monem 2, Tarek Emran
More informationREVIEW ARTICLE NEWER BIOMARKERS IN EARLY DIABETIC NEPHROPATHY
JCD REVIEW ARTICLE NEWER BIOMARKERS IN EARLY DIABETIC NEPHROPATHY SAPTARSHI MUKHOPADHYAY* *FACULTY (DEPARTMENT OF MEDICINE), B R SINGH HOSPITAL (EASTERN RAILWAY), KOLKATA. INTRODUCTION renal disease. It
More informationRenal Protection Staying on Target
Update Staying on Target James Barton, MD, FRCPC As presented at the University of Saskatchewan's Management of Diabetes & Its Complications (May 2004) Gwen s case Gwen, 49, asks you to take on her primary
More informationDr. Mehmet Kanbay Department of Medicine Division of Nephrology Istanbul Medeniyet University School of Medicine Istanbul, Turkey.
The uric acid dilemma: causal risk factor for hypertension and CKD or mere bystander? Mehmet Kanbay, Istanbul, Turkey Chairs: Anton H. van den Meiracker, Rotterdam, The Netherlands Claudia R.C. Van Roeyen,
More informationEzetimibe Reduces Urinary Albumin Excretion in Hypercholesterolaemic Type 2 Diabetes Patients with Microalbuminuria
The Journal of International Medical Research 2012; 40: 798 803 Ezetimibe Reduces Urinary Albumin Excretion in Hypercholesterolaemic Type 2 Diabetes Patients with Microalbuminuria T NAKAMURA 1, E SATO
More informationREVIEW ARTICLE. Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease
Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease Causal or Casual? REVIEW ARTICLE William G. Christen, ScD; Umed A. Ajani, MBBS; Robert J. Glynn, ScD; Charles H. Hennekens, MD
More informationEvaluation. Abstract: Introduction: Micro-vascular. ESRD. Due ARTICLE 1,2. treatment for DM Bhubaneswar life span resulting 3 Tutor.
ORIGINAL RESEARCH ARTICLE http: ://www.eternalpublication.com INTERNATIONAL JOURNAL OF ANATOMY PHYSIOLOGY AND BIOCHEMISTRY IJAPB: Volume: 2; Issue: 6; June 2015 ISSN(Online):2394-3440 Evaluation of Biochemical
More informationDisclosures. Outline. Outline 5/23/17 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationDisclosures. Outline. Outline 7/27/2017 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationPlasma homocysteine concentrations in a Belgian school-age population 1 3
Plasma homocysteine concentrations in a Belgian school-age population 1 3 Corinne De Laet, Jean-Claude Wautrecht, Daniel Brasseur, Michèle Dramaix, Jean-Marie Boeynaems, Jean Decuyper, and André Kahn ABSTRACT
More informationCreatinine & egfr A Clinical Perspective. Suheir Assady MD, PhD Dept. of Nephrology & Hypertension RHCC
Creatinine & egfr A Clinical Perspective Suheir Assady MD, PhD Dept. of Nephrology & Hypertension RHCC CLINICAL CONDITIONS WHERE ASSESSMENT OF GFR IS IMPORTANT Stevens et al. J Am Soc Nephrol 20: 2305
More informationInsulin resistance is a fundamental abnormality
Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Fasting Plasma Homocysteine Levels in the Insulin Resistance Syndrome The Framingham Offspring Study JAMES B. MEIGS, MD,
More informationACE Inhibitors and Protection Against Kidney Disease Progression in Patients With Type 2 Diabetes: What s the Evidence?
Reviews ACE Inhibitors and Protection Against Kidney Disease Progression in Patients With Type 2 Diabetes: What s the Evidence? George L. Bakris, MD; 1 and Matthew Weir, MD 2 Although angiotensin-converting
More informationEuropean Journal of Clinical Investigation (2003) 33, VU University Medical Center, Amsterdam, the Netherlands
European Journal of Clinical Investigation (2003) 33, 17 25 Blackwell Science, Ltd S-adenosylhomocysteine and the ratio of S-adenosylmethionine to S-adenosylhomocysteine are not related to folate, cobalamin
More informationRelationship Between Sialic Acid and Microvascular Complications in Type 2 Diabetes Mellitus
Proceeding S.Z.P.G.M.I. Vol: 24(2): pp. 79-83, 2010. Relationship Between Sialic Acid and Microvascular Complications in Type 2 Diabetes Mellitus Mohammad Jawaid Subzwari, 1 Manzoor Ahmed Qureshi 2, Amjad
More informationSTUDY ON MICROALBUMINURIA AND OXIDATIVESTRESS IN DIABETICS. B. Suneel, R.R.Aparna, D.Balakrishna, B.Sowjanya and M.Audisesha Reddy.
Volume: 2: Issue-4: Oct - Dec -2011 ISSN 0976-4550 STUDY ON MICROALBUMINURIA AND OXIDATIVESTRESS IN DIABETICS * B. Suneel, R.R.Aparna, D.Balakrishna, B.Sowjanya and M.Audisesha Reddy. * Department of Biochemistry,
More informationMicrovascular Disease in Type 1 Diabetes
Microvascular Disease in Type 1 Diabetes Jay S. Skyler, MD, MACP Division of Endocrinology, Diabetes, and Metabolism and Diabetes Research Institute University of Miami Miller School of Medicine The Course
More informationSerum Cystatin C Levels in Children with Nephrosis or Diabetes: A Pilot Study
Serum Cystatin C Levels in Children with Nephrosis or Diabetes: A Pilot Study Tülin Ayse, Özden, PhD * Ayse, Palandüz, MD Cahide. Anıl Gökkusu,, PhD Halim Issever,, PhD * Istanbul University, Institute
More informationHyperhomocysteinaemia in Black patients with cerebral thrombosis
Q J Med 1997; 90:635-639 Hyperhomocysteinaemia in Black patients with cerebral thrombosis R. DELPORT 1, J.B. UBBINK\ W.J.H. VERMAAK 1, H. ROSSOUW 1, P.J. BECKER 2 andj. JOUBERT 3 * From the ^Department
More informationHOMOCYSTEINE (H(e)) is a nonprotein-forming, thiolcontaining
0163-769X/99/$03.00/0 Endocrine Reviews 20(5): 738 759 Copyright 1999 by The Endocrine Society Printed in U.S.A. Hyperhomocysteinemia and the Endocrine System: Implications for Atherosclerosis and Thrombosis
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Protein Restriction to prevent the progression of diabetic nephropathy GUIDELINES
Protein Restriction to prevent the progression of diabetic nephropathy Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES a. A small volume of evidence suggests
More informationImpairment of homocysteine metabolism in patients with retinal vascular occlusion and non-arteritic ischemic optic neuropathy
Clin Chem Lab Med 2005;43(10):1020 1025 2005 by Walter de Gruyter Berlin New York. DOI 10.1515/CCLM.2005.179 2005/230 Impairment of homocysteine metabolism in patients with retinal vascular occlusion and
More informationQUICK REFERENCE FOR HEALTHCARE PROVIDERS
KEY MESSAGES 1 SCREENING CRITERIA Screen: Patients with DM and/or hypertension at least yearly. Consider screening patients with: Age >65 years old Family history of stage 5 CKD or hereditary kidney disease
More informationPrevalence of anemia and cardiovascular diseases in chronic kidney disease patients: a single tertiary care centre study
International Journal of Advances in Medicine Sathyan S et al. Int J Adv Med. 2017 Feb;4(1):247-251 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20170120
More informationMarkers of Endothelial Dysfunction and Inflammation in Type 1 Diabetic Patients With or Without Diabetic Nephropathy Followed for 10 Years
Pathophysiology/Complications O R I G I N A L A R T I C L E Markers of Endothelial Dysfunction and Inflammation in Type 1 Diabetic Patients With or Without Diabetic Nephropathy Followed for 10 Years Association
More informationReversal of Microalbuminuria A Causative Factor of Diabetic Nephropathy is Achieved with ACE Inhibitors than Strict Glycemic Control
ISSN 0976 3333 Available Online at www.ijpba.info International Journal of Pharmaceutical & Biological Archives 2013; 4(5): 923-928 ORIGINAL RESEARCH ARTICLE Reversal of Microalbuminuria A Causative Factor
More informationOutline. Outline. Introduction CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 8/11/2011
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationImpaired protein tolerance test as a marker of early renal dysfunction in type 2 diabetes mellitus
Original Research Article Impaired protein tolerance test as a marker of early renal dysfunction in type 2 diabetes mellitus Devabhaktuni Siva Sankar 1, Shaik Khaja Rassul 1* 1 Assistant Professor of Medicine,
More informationHOMOCYSTEINE. A Strong Risk Factor for Cardiovascular Disease INNOVATIONS IN CLINICAL DIAGNOSTICS
HOMOCYSTEINE A Strong Risk Factor for Cardiovascular Disease INNOVATIONS IN CLINICAL DIAGNOSTICS About Diazyme Diazyme Laboratories, Inc., an affiliate of General Atomics, is located in Poway, California.
More informationHyperhomocysteinemia in Chronic Renal Disease
DISEASE OF THE MONTH J Am Soc Nephrol 10: 891 900, 1999 Hyperhomocysteinemia in Chronic Renal Disease ANDREW G. BOSTOM* and BRUCE F. CULLETON *Memorial Hospital of Rhode Island, Pawtucket, Rhode Island;
More informationRisk factors associated with the development of overt nephropathy in type 2 diabetes patients: A 12 years observational study
Indian J Med Res 136, July 2012, pp 46-53 Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: A 12 years observational study Vijay Viswanathan, Priyanka Tilak
More informationDiabetic nephropathy affects 25 30% of type 1
Low Glomerular Filtration Rate in Normoalbuminuric Type 1 Diabetic Patients An Indicator of More Advanced Glomerular Lesions M. Luiza Caramori, 1 Paola Fioretto, 2 and Michael Mauer 1 Increased urinary
More informationThe interest in microalbuminuria originated. Cardiovascular Implications of Albuminuria. R e v i e w P a p e r.
R e v i e w P a p e r Cardiovascular Implications of Albuminuria Katherine R. Tuttle, MD Microalbuminuria is a major independent risk factor for cardiovascular disease (CVD) events in persons with diabetes
More informationDiabetic Nephropathy. Objectives:
There are, in truth, no specialties in medicine, since to know fully many of the most important diseases a man must be familiar with their manifestations in many organs. William Osler 1894. Objectives:
More informationIn type 2 diabetes, there is a strong association
Increased Urinary Albumin Excretion, Endothelial Dysfunction, and Chronic Low-Grade Inflammation in Type 2 Diabetes Progressive, Interrelated, and Independently Associated With Risk of Death Coen D.A.
More informationA study of predictive value of microalbuminuria in early outcome of non-diabetic patients of acute myocardial infarction
International Journal of Advances in Medicine Patel SR et al. Int J Adv Med. 2017 Apr;4(2):334-338 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20170523
More informationCHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationOutline. Introduction. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 6/26/2012
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationLow-Dose Candesartan Cilexetil Prevents Early Kidney Damage in Type 2 Diabetic Patients with Mildly Elevated Blood Pressure
453 Original Article Low-Dose Candesartan Cilexetil Prevents Early Kidney Damage in Type 2 Diabetic Patients with Mildly Elevated Blood Pressure Satoru MURAYAMA, Tsutomu HIRANO, Taro SAKAUE, Kenta OKADA,
More informationISN Mission: Advancing the diagnosis, treatment and prevention of kidney diseases in the developing and developed world
ISN Mission: Advancing the diagnosis, treatment and prevention of kidney diseases in the developing and developed world Nutrition in Kidney Disease: How to Apply Guidelines to Clinical Practice? T. Alp
More informationEffect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine
Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine Vojtech Melenovsky, MD, PhD, a,c Tomas Stulc, MD, a Viktor Kozich, MD, PhD, b Barbora Grauova, MD, PhD, a Jakub Krijt,
More information1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria
1. Albuminuria an early sign of glomerular damage and renal disease albuminuria Cardio-renal continuum REGRESS Target organ damage Asymptomatic CKD New risk factors Atherosclerosis Target organ damage
More informationIncreased Risk of Renal Deterioration Associated with Low e-gfr in Type 2 Diabetes Mellitus Only in Albuminuric Subjects
ORIGINAL ARTICLE Increased Risk of Renal Deterioration Associated with Low e-gfr in Type 2 Diabetes Mellitus Only in Albuminuric Subjects Shu Meguro, Toshikatsu Shigihara, Yusuke Kabeya, Masuomi Tomita
More informationRenal Function and Associated Laboratory Tests
Renal Function and Associated Laboratory Tests Contents Glomerular Filtration Rate (GFR)... 2 Cockroft-Gault Calculation of Creatinine Clearance... 3 Blood Urea Nitrogen (BUN) to Serum Creatinine (SCr)
More informationDr. Hayam Gad Associate Professor of Physiology College of Medicine King Saud University
Dr. Hayam Gad Associate Professor of Physiology College of Medicine King Saud University INTRODUCTION Diabetic nephropathy (DN) DN is defined as the appearance of persistent clinical albuminuria in an
More informationSerum and urinary markers of early impairment of GFR in chronic kidney disease patients: diagnostic accuracy of urinary -trace protein
Am J Physiol Renal Physiol 299: F1407 F1423, 2010. First published September 15, 2010; doi:10.1152/ajprenal.00507.2009. Serum and urinary markers of early impairment of GFR in chronic kidney disease patients:
More informationCHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH SCIENTIFIC DIRECTOR KIDNEY HEALTH RESEARCH COLLABORATIVE - UCSF CHIEF - GENERAL INTERNAL MEDICINE, SAN FRANCISCO
More informationSeung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine
Seung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine Age and Kidney Weight renal weight and thickening of the vascular intima Platt et al. Gerentology 1999;45:243-253
More informationThe study of correlation of silent myocardial ischemia with microalbuminuria in patients of type 2 diabetes mellitus
International Journal of Advances in Medicine Dua HS et al. Int J Adv Med. 2017 Dec;4(6):1506-1512 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20175120
More informationAdvances in Environmental Biology
Advances in Environmental Biology, 9() November 15, Pages: 191-195 AENSI Journals Advances in Environmental Biology ISSN-1995-75 EISSN-199-1 Journal home page: http://www.aensiweb.com/aeb/ Effects of Active
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Antihypertensive therapy in diabetic nephropathy GUIDELINES
Antihypertensive therapy in diabetic nephropathy Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES a. Adequate control of blood pressure (BP) slows progression
More informationHyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes
Kidney International, Vol. 52 (1997), pp. 10 20 PERSPECTIVES IN BASIC SCIENCE Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes
More informationThe kidney. (Pseudo) Practical questions. The kidneys are all about keeping the body s homeostasis. for questions Ella
The kidney (Pseudo) Practical questions for questions Ella (striemit@gmail.com) The kidneys are all about keeping the body s homeostasis Ingestion Product of metabolism H 2 O Ca ++ Cl - K + Na + H 2 O
More informationCardiovascular disease is the major cause of death in. Clinical Investigation and Reports
Clinical Investigation and Reports Hyperhomocysteinemia Increases Risk of Death, Especially in Type 2 Diabetes 5-Year Follow-Up of the Hoorn Study Ellen K. Hoogeveen, MD, PhD; Pieter J. Kostense, PhD;
More informationAnalysis of spectrum of chronic kidney disease in IPD and OPD
FOOD SCIENCE RESEARCHPAPER RESEARCH JOURNAL e ISSN-2230-9403 Visit us : www.researchjournal.co.in Volume 6 Issue 2 October, 2015 246-250 DOI : 10.15740/HAS/FSRJ/6.2/246-250 Analysis of spectrum of chronic
More information